Does phenylbutyrate mouthwash mitigate oral mucositis during radiotherapy or chemoradiotherapy in patients with head-and-neck cancer?
This pilot trial suggested that phenylbutyrate mouthwash significantly decreased the impact of OM in HNC patients receiving RT or chemoradiotherapy and did not confront the tumor control. Larger Phase II randomized trials are needed to confirm these results.
LOX-1 activation may play an important role in H(2)O(2)-induced apoptosis of rat myocardial cells.